For subscribers
S’pore biotech firms making inroads into US, the world’s biggest healthcare spender
Sign up now: Get ST's newsletters delivered to your inbox
Lucence founder Tan Min-Han in the biotech company's laboratory in Palo Alto, California.
ST PHOTO: CHARISSA YONG
Follow topic:
SAN FRANCISCO – When biotech start-up Lucence began setting up its medical laboratory in the United States in August 2020, it faced long waits for equipment amid supply chain snarls caused by the Covid-19 pandemic.
Vendors would give the firm the cold shoulder because they wanted to prioritise supplies for Covid-19 tests over what Lucence needed for its cancer-detecting blood tests, said the company’s founder, Dr Tan Min-Han.
